The Roots Analysis report features an extensive study of the current market landscape, offering an informed opinion on the likely evolution of the next-generation complement therapeutics in the therapy of various complement-mediated diseases. The study underlines an in-depth analysis, highlighting the diverse capabilities of players engaged in this domain. One of the key objectives of the report was to identify the primary growth drivers and estimate future growth opportunities.
